What is Clarametyx Biosciences worth?
$92.0Mlast known valuation
Clarametyx Biosciences last raised $27.5M in its Early Stage VC (Jan 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Clarametyx Biosciences
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2024 | Early Stage VC | $27.5M | ▮ | ▮ |
How Clarametyx Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Clarametyx Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Clarametyx Biosciences worth?
- Clarametyx Biosciences's last known valuation is $92.0M.
- How much has Clarametyx Biosciences raised?
- Clarametyx Biosciences has raised $44.0M in total funding across 1 recorded rounds.
- When did Clarametyx Biosciences last raise?
- Clarametyx Biosciences last raised in Jan 2024 (Early Stage VC), raising $27.5M.